Analysis of Financial Performance of Selected Pharmaceutical Companies of India PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Analysis of Financial Performance of Selected Pharmaceutical Companies of India PDF full book. Access full book title Analysis of Financial Performance of Selected Pharmaceutical Companies of India by P. Rohitkumar. Download full books in PDF and EPUB format.
Author: P. Rohitkumar Publisher: Infotech Publishers ISBN: 9784158373520 Category : Business & Economics Languages : en Pages : 0
Book Description
GLOBAL PHARMACEUTICAL INDUSTRY The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug firms control more than one-third of this market, many with annual revenue of \ more than US$ 10 billion and profit margins of about 30%. Six are based in the \sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.
Author: P. Rohitkumar Publisher: Infotech Publishers ISBN: 9784158373520 Category : Business & Economics Languages : en Pages : 0
Book Description
GLOBAL PHARMACEUTICAL INDUSTRY The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug firms control more than one-third of this market, many with annual revenue of \ more than US$ 10 billion and profit margins of about 30%. Six are based in the \sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.
Author: Mithun Nandy Publisher: Springer Nature ISBN: 981166921X Category : Business & Economics Languages : en Pages : 224
Book Description
The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the ‘Pharmacy of the World’ and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as ‘Innovate in India and Serve to the World’. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach.
Author: Mainak Mazumdar Publisher: Physica ISBN: 9783790828771 Category : Business & Economics Languages : en Pages : 202
Book Description
This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic analysis of firm strategies due to recent policy changes. The book is useful for researchers interested in understanding the transition of a lifeline sector for an emerging economy like India. Students of public policy, health administrators and health economists who are interested in the functioning of the pharmaceutical sector that produces life saving drugs in developing nations will find this book useful. The book also provides good coverage on data envelopment analysis (DEA), a useful technique for understanding productivity and efficiency. It can provide guidance to the research students on the applicability of DEA technique to address various research questions for analysis. The book will be a valuable addition to libraries in colleges of pharmacy and medicine as well as to all other academic and research centers.
Author: Daniel Andriessen Publisher: Routledge ISBN: 1136386599 Category : Business & Economics Languages : en Pages : 453
Book Description
Peter Drucker has introduced us all to the knowledge era, where knowledge is the primary resource and intangibles (intellectual capital resources and assets) are now largely recognized as the most important sources of organizations' competitive advantage. With the recognition of the importance of Intangibles comes the problem of how to properly identify them and assign them a value within the corporation. This is an area of concern in 5 fields: 1) accounting and financial reporting, 2) performance measurement and management, 3) valuation in the finance field, 4) the Human Resources field in terms of management, strategy, and planning, and 5) Intellectual Capital. Over the past eight years, over 25 methods have been proposed for the valuation of intangibles coming out of these 5 fields. In this book, Andriessen evaluates 25 existing methods of intangible valuation according to highly developed criteria. In performing his evaluations, Andriessen synthesizes the state of the art research from these fields based on extensive research. He then presents his own method for valuing intangibles, which he began developing and testing as a Senior Manager at KPMG Knowledge Advisory Services in The Netherlands. He relates six case studies in which this method was tested in actual companies, carefully reviews the results of his tests, and then concludes by offering a new and improved method for valuing intangibles in his Weightless Wealth Toolkit, a complete step-by-step process for identifying, valuing, and managing Intangibles to help managers operate successfully in the Intangible Economy.
Author: I. M. PANDEY Publisher: PHI Learning Pvt. Ltd. ISBN: 9788120309180 Category : Business & Economics Languages : en Pages : 252
Book Description
A "what" and "how" guide for managers who do not have a formal background in finance, this book equips them to perform their tasks more effectively and efficiently. It describes the application of concepts of finance in the decision-making of operating managers. The book follows a simple, non-technical language in explaining the concepts of finance. The text is divided into three parts : Part I on Financial Analysis deals with profit and loss statement, financial ratios and funds flow statement. Part II on Cost Analysis is devoted to a discussion on the concepts of cost, utility of costs in decision making, and profit planning and control. Part III on Funds Management explains the techniques of fund allocation, working capital management, and financial planning and policy. This book is made reader-friendly by its lucid presentation of topics and by adopting a practical situational approach in solving problems. Besides practising operational managers, all those preparing for professional examinations would find this book to be of enormous help to them. The book is also suitable for students of business management.
Author: Dr. Sanjay R. Ajmeri Publisher: Allied Publishers ISBN: 819429035X Category : Business & Economics Languages : en Pages : 344
Book Description
This book is a compendium of papers presented in the International Conference on Emerging Global Economic Situation: Impact on Trade and Agribusiness in India jointly organised by Agro-Economic Research Centre (AERC) of Sardar Patel University, Vallabh Vidyanagar, Anand (Gujarat) and Bhikhabhai Jivabhai Vanijya Mahavidyalaya (BJVM), Vallabh Vidyanagar during September 28-29, 2018 with the support of Ministry of Agriculture and Farmers Welfare, Government of India and National Bank for Agriculture and Rural Development (NABARD), Ahmedabad. This book will be very useful for all those interested in issues related to international business and commerce.
Author: Yaeko Mitsumori Publisher: Springer ISBN: 9811067902 Category : Business & Economics Languages : en Pages : 120
Book Description
This study analyzes the impact of the revision of the Indian Patent Act (2005) on the Indian pharmaceutical industry, which has been achieving healthy growth over the past 30 to 40 years or more. As of 2005, the Indian pharmaceutical industry was ranked as No. 4 in the world in terms of volume and 15th in terms of value. WTO/TRIPS required India to revise its patent law, however, and to introduce product patents in the pharmaceutical field. Many not only in India but also in the world had argued that the local pharmaceutical industry could deteriorate once a strong patent law (such as a product patent) was introduced. However, the Indian pharmaceutical industry has continued to develop rapidly even after the revision of the patent law in 2005. This present study started with efforts to work out the reason the Indian pharmaceutical industry successfully expanded even after the introduction of product patents. The study found that a unique article (the so-called '3-d‘) inserted in the Patent Act 2005 might have played a role in diminishing or preventing a negative impact from the introduction of a strong patent system, such as a product patents. The study also considers that a change of the business model adopted by the Indian pharmaceutical industry might have contributed to diminishing the effect of the negative impact from the introduction of a strong patent law. This study also covers recent developments in India regarding intellectual property rights and the pharmaceutical industry. One is India’s very first compulsory license granted to an Indian pharmaceutical company, Natco, against the large German pharmaceutical firm Bayer; and the second is the Supreme Court decision on Novartis’ Gleevec. The study analyzes the fundamental problems that caused these two events: access to medicine and gaps in the concept of intellectual property in the pharmaceutical industry. As possible solutions to these fundamental issues, this book explores the ideas of voluntary licensing and tiered pricing.
Author: Hans Löfgren Publisher: Springer ISBN: 1137315857 Category : Political Science Languages : en Pages : 265
Book Description
Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.
Author: P. Rohitkumar
Author: P. Rohitkumar
Author: Mithun Nandy
Author: Mainak Mazumdar
Author: Dr. SYED KHAJA SAFIUDDIN
Author: Daniel Andriessen
Author: Sruthi. S, Dr.Pragya Singh ,Er. Yogendra Kumar
Author: I. M. PANDEY
Author: Dr. Sanjay R. Ajmeri
Author: Yaeko Mitsumori
Author: Hans Löfgren